1.
Sglt-2 Inhibitors in Diabetic Type 2 Patients Nephroprotective Effects of (Empagliflozin). Gen. Rep. [Internet]. 2023 Nov. 6 [cited 2025 Aug. 2];26:1-4. Available from: https://geniusrepo.net/index.php/1/article/view/277